Draft guidance on statins
The National Institute for Health and Care Excellence (NICE) is recommending that the threshold for starting statins for the preventive treatment of cardiovascular disease (CVD) is halved from a 20% risk of developing CVD over 10 years to a 10% risk. This draft guidance – an update on its 2008 lipid modification guidance – follows new evidence for CVD risk assessment tools and the availability of generic statins.
Pay to access this premium content £5
You can access this article without logging in.But don't miss out on the many Benefits of our Membership. Register Now.Already a member? Login Now.